BACKGROUND AND PURPOSE: Cannabis is the most popular drug used in the European Union, closely followed by cocaine. Whereas cannabis impairs neurocognitive function in occasional cannabis users, such impairments appear less prominent in heavy users, possibly as a result of tolerance. The present study was designed to assess whether the impairing effects of Δ(9) -tetrahydrocannabinol (THC) in heavy cannabis users would present in a wide range of neuropsychological functions or selectively affect specific performance domains. We also assessed the acute effects of cocaine on neurocognitive functions of heavy cannabis users. EXPERIMENTAL APPROACH: Heavy cannabis users, who had a history of cocaine use (n = 61), participated in a double-blind, placebo-controlled, three-way crossover study. Subjects received single doses of cocaine HCl (300 mg), cannabis (THC μg·kg(-1) ) and placebo, and completed a number of tests measuring impulse control and psychomotor function. KEY RESULTS: Single doses of cannabis impaired psychomotor function and increased response errors during impulsivity tasks. Single doses of cocaine improved psychomotor function and decreased response time in impulsivity tasks, but increased errors. CONCLUSIONS AND IMPLICATIONS: Heavy cannabis users display impairments in a broad range of neuropsychological domains during THC intoxication. Impairments observed in psychomotor tasks, but not in impulsivity tasks, appeared smaller in magnitude as compared with those previously reported in occasional cannabis users. Heavy cannabis users were sensitive to the stimulating and inhibitory effects of cocaine on psychomotor function and impulsivity respectively. The reduction in proficiency in impulse control may put drug users at increased risk of repeated drug use and addiction.
RCT Entities:
BACKGROUND AND PURPOSE: Cannabis is the most popular drug used in the European Union, closely followed by cocaine. Whereas cannabis impairs neurocognitive function in occasional cannabis users, such impairments appear less prominent in heavy users, possibly as a result of tolerance. The present study was designed to assess whether the impairing effects of Δ(9) -tetrahydrocannabinol (THC) in heavy cannabis users would present in a wide range of neuropsychological functions or selectively affect specific performance domains. We also assessed the acute effects of cocaine on neurocognitive functions of heavy cannabis users. EXPERIMENTAL APPROACH: Heavy cannabis users, who had a history of cocaine use (n = 61), participated in a double-blind, placebo-controlled, three-way crossover study. Subjects received single doses of cocaine HCl (300 mg), cannabis (THC μg·kg(-1) ) and placebo, and completed a number of tests measuring impulse control and psychomotor function. KEY RESULTS: Single doses of cannabis impaired psychomotor function and increased response errors during impulsivity tasks. Single doses of cocaine improved psychomotor function and decreased response time in impulsivity tasks, but increased errors. CONCLUSIONS AND IMPLICATIONS: Heavy cannabis users display impairments in a broad range of neuropsychological domains during THC intoxication. Impairments observed in psychomotor tasks, but not in impulsivity tasks, appeared smaller in magnitude as compared with those previously reported in occasional cannabis users. Heavy cannabis users were sensitive to the stimulating and inhibitory effects of cocaine on psychomotor function and impulsivity respectively. The reduction in proficiency in impulse control may put drug users at increased risk of repeated drug use and addiction.
Authors: Nina B L Urban; Mark Slifstein; Judy L Thompson; Xiaoyan Xu; Ragy R Girgis; Sonia Raheja; Margaret Haney; Anissa Abi-Dargham Journal: Biol Psychiatry Date: 2012-01-29 Impact factor: 13.382
Authors: Stefan W Toennes; Kirsten Schneider; Gerold F Kauert; Cora Wunder; Manfred R Moeller; Eef L Theunissen; Johannes G Ramaekers Journal: Anal Bioanal Chem Date: 2010-11-30 Impact factor: 4.142
Authors: Emma Barkus; Paul D Morrison; D Vuletic; John C Dickson; Peter J Ell; Lyn S Pilowsky; Rudolf Brenneisen; David W Holt; John Powell; Shitij Kapur; Robin M Murray Journal: J Psychopharmacol Date: 2010-09-17 Impact factor: 4.153
Authors: Carl L Hart; Aaron B Ilan; Alan Gevins; Erik W Gunderson; Kemi Role; Jana Colley; Richard W Foltin Journal: Pharmacol Biochem Behav Date: 2010-06-18 Impact factor: 3.533
Authors: Stefan W Toennes; Johannes G Ramaekers; Eef L Theunissen; Manfred R Moeller; Gerold F Kauert Journal: J Anal Toxicol Date: 2008-09 Impact factor: 3.367
Authors: Jane Metrik; Christopher W Kahler; Brady Reynolds; John E McGeary; Peter M Monti; Margaret Haney; Harriet de Wit; Damaris J Rohsenow Journal: Psychopharmacology (Berl) Date: 2012-05-16 Impact factor: 4.530
Authors: Claudio Zanettini; Leigh V Panlilio; Mano Alicki; Steven R Goldberg; József Haller; Sevil Yasar Journal: Front Behav Neurosci Date: 2011-09-13 Impact factor: 3.558
Authors: Rebecca Kuepper; Jenny Ceccarini; Johan Lataster; Jim van Os; Marinus van Kroonenburgh; Joop M A van Gerven; Machteld Marcelis; Koen Van Laere; Cécile Henquet Journal: PLoS One Date: 2013-07-25 Impact factor: 3.240
Authors: Nathalie A Desrosiers; Johannes G Ramaekers; Emeline Chauchard; David A Gorelick; Marilyn A Huestis Journal: J Anal Toxicol Date: 2015-03-04 Impact factor: 3.367
Authors: David S Jacobs; Stephen J Kohut; Shan Jiang; Spyros P Nikas; Alexandros Makriyannis; Jack Bergman Journal: Exp Clin Psychopharmacol Date: 2016-08-15 Impact factor: 3.157
Authors: Hollis C Karoly; Michael A Milburn; Ashley Brooks-Russell; Mary Brown; Jessica Streufert; Angela D Bryan; Nicholas P Lovrich; William DeJong; L Cinnamon Bidwell Journal: Cannabis Cannabinoid Res Date: 2020-09-10
Authors: J G Ramaekers; J H van Wel; D Spronk; B Franke; G Kenis; S W Toennes; K P C Kuypers; E L Theunissen; P Stiers; R J Verkes Journal: Brain Imaging Behav Date: 2016-12 Impact factor: 3.978
Authors: Nadia Rpw Hutten; Kim Pc Kuypers; Janelle Hp van Wel; Eef L Theunissen; Stefan W Toennes; Robbert-Jan Verkes; Johannes G Ramaekers Journal: J Psychopharmacol Date: 2018-06-27 Impact factor: 4.153
Authors: Desirée B Spronk; Marieke E Van der Schaaf; Roshan Cools; Ellen R A De Bruijn; Barbara Franke; Janelle H P van Wel; Johannes G Ramaekers; Robbert J Verkes Journal: Psychopharmacology (Berl) Date: 2015-11-17 Impact factor: 4.530
Authors: J G Ramaekers; J H van Wel; D B Spronk; S W Toennes; K P C Kuypers; E L Theunissen; R J Verkes Journal: Sci Rep Date: 2016-05-26 Impact factor: 4.379